MRX — Stock Film
STOCK FILMSCENE 1/11MRX · $69.59
Stock Expert AI presents
MRX
Marex Group Limited
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Marex Group Limited. A quick introduction.

On the stock market since 2024, it operates in the world of money and finance. It has 3,224 employees. Now — the numbers.

on the stock market since 2024
3,224 employees
$4.3B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $8 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 8%

This is an established company with proven profits.

THE SALES TREND
Sales are growing, year after year.

Average growth of 44% a year over the last 4 years. Every year shown ended in profit.

$851.7M
2021
$1.2B
2022
$2.4B
2023
$2.9B
2024
$3.6B
2025
Every quarter, analysts set a profit bar.
How many of the last 6 did the company clear?
6 / 6
EXPECTATIONS MET OR BEATEN
6
Aug 2024
Mar 2025
Nov 2025
Mar 2026
May 2026
Aug 2026
6 TIMES IN THE LAST 6 QUARTERS
It clears the bar, quarter after quarter.
What executives did with their own stock over the last 12 months:
6 buy69 sell

Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
Executives aren’t buying3/10
WORTH WATCHING

Executive Buying: The trades send no strong signal of confidence.

THE FIVE-YEAR JOURNEY
Bumpy, but the direction is up.

The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.

1
THE BRIGHT SIDE · 1/3
Sales keep climbing

Over the last 3 years, sales grew about 46% a year on average.

2
THE BRIGHT SIDE · 2/3
Delivers on expectations

It met or beat analyst expectations in 6 of the last 6 quarters — consistency is a promise kept.

3
THE BRIGHT SIDE · 3/3
Analysts’ target sits above today’s price

The average analyst price target is $81.8318% above today’s price.

1
THE RISKS · 1/2
Executives lean toward selling

Over the last 12 months, executives reported 69 sells against just 6 buys. Not an alarm bell by itself, but a number worth watching.

2
THE RISKS · 2/2
Executives aren’t buying

No clear buy-side message is coming from the executive floor. Council score: 3/10.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, MRX sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: MRX is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film